Harvard Bioscience
HBIO
#9013
Rank
NZ$0.15 B
Marketcap
$3.56
Share price
-6.45%
Change (1 day)
-54.86%
Change (1 year)

Earnings for Harvard Bioscience (HBIO)

Earnings in 2024 (TTM): -NZ$21.72 Million

According to Harvard Bioscience's latest financial reports the company's current earnings are NZ$97.73 Million. In 2023 the company made an earning of -NZ$4.49 Million, an increase over its 2022 earnings that were of -NZ$16.11 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Harvard Bioscience from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$21.72 Million384.22%
2023 -NZ$4.49 Million-72.15%
2022 -NZ$16.11 Million6456.43%
2021 -NZ$0.25 Million-98.08%
2020 -NZ$12.8 Million32.53%
2019 -NZ$9.66 Million-31.01%
2018 -NZ$14 Million243.9%
2017 -NZ$4.07 Million-24.66%
2016 -NZ$5.41 Million-14.69%
2015 -NZ$6.34 Million-181.68%
2014 NZ$7.75 M-9.97%
2013 NZ$8.6 M120%
2012 NZ$3.91 M-50.9%
2011 NZ$7.96 M-52.51%
2010 NZ$16.78 M-2.53%
2009 NZ$17.21 M28.26%
2008 NZ$13.42 M-20.05%
2007 NZ$16.78 M13.96%
2006 NZ$14.73 M17.59%
2005 NZ$12.52 M57.37%
2004 NZ$7.96 M-37.31%
2003 NZ$12.69 M208.03%
2002 NZ$4.12 M-168.71%
2001 -NZ$6 Million-66.89%
2000 -NZ$18.12 Million